Cardiomyopathies, heart failure, and arrhythmias or conduction blockages impact millions
of patients worldwide and are associated with marked increases in sudden cardiac death,
decline in the quality of life, and the induction of secondary pathologies. These
pathologies stem from dysfunction in the contractile or conductive properties of the
cardiomyocyte, which as a result is a focus of fundamental investigation, drug discovery
and therapeutic development, and tissue engineering. All of these foci require
in
vitro
myocardial models and experimental techniques to probe the physiological
functions of the cardiomyocyte. In this review, we provide a detailed exploration of
different cell models, disease modeling strategies, and tissue constructs used from basic
to translational research. Furthermore, we highlight recent advancements in imaging,
electrophysiology, metabolic measurements, and mechanical and contractile characterization
modalities that are advancing our understanding of cardiomyocyte physiology. With this
review, we aim to both provide a biological framework for engineers contributing to the
field and demonstrate the technical basis and limitations underlying physiological
measurement modalities for biologists attempting to take advantage of these
state-of-the-art techniques.